Novagenix determines, develops and validates the analytical methods required for physical and chemical analysis of the formulations it has developed. This current pharmacopoeia for analytical work (Turkey Pharmacopoeia, European Pharmacopoeia, United States Pharmacopoeia and British Pharmacopoeia) and Turkey Ministry of Health, Pharmaceutical Development ICH Q8 (R2) takes into account the regulations and guides. Laboratory quality management system complies with ISO 9001 and 17025 standards.
• LC-MS/MS : WATERS Xevo G2-XS ve APGC w/H-CLASS UPLC
• AAS: SHIMADZU AA-7000
• HPLC : AGILENT 1100 SERIES w/DAD, FLD, UV detectors (x 10)